Xoma, Ltd. - General Releaseshttp://investors.xoma.com/releases.cfm?sh_auth=767336991.0.0.09bf50d2076e3e4e81d0665bac286e2fXoma, Ltd. - General Releasesen-usShareholder.com RSS FeedXOMA Receives NASDAQ Determination Letterhttp://investors.xoma.com/releasedetail.cfm?ReleaseID=425595Thu, 19 Nov 2009 21:09:23 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=425595XOMA Receives NASDAQ Determination LetterXOMA Appoints Jim Neal Vice President of Business Developmenthttp://investors.xoma.com/releasedetail.cfm?ReleaseID=424646Tue, 17 Nov 2009 13:00:15 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=424646XOMA Appoints Jim Neal Vice President of Business DevelopmentXOMA 052 Selected as a Top Ten Project to Watchhttp://investors.xoma.com/releasedetail.cfm?ReleaseID=423951Thu, 12 Nov 2009 20:18:00 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=423951XOMA 052 Selected as a Top Ten Project to WatchXOMA Announces Presentation at Lazard Healthcare Conference on November 18http://investors.xoma.com/releasedetail.cfm?ReleaseID=423634Wed, 11 Nov 2009 19:30:27 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=423634XOMA Announces Presentation at Lazard Healthcare Conference on November 18XOMA Reports 2009 Third Quarter Financial Resultshttp://investors.xoma.com/releasedetail.cfm?ReleaseID=422750Mon, 09 Nov 2009 13:00:40 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=422750XOMA Reports 2009 Third Quarter Financial ResultsXOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseaseshttp://investors.xoma.com/releasedetail.cfm?ReleaseID=422494Fri, 06 Nov 2009 13:00:48 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=422494XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular DiseasesPhase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes Patientshttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421746Wed, 04 Nov 2009 13:04:57 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421746Phase 2 Trial of XOMA 052 to be Initiated in Type 1 Diabetes PatientsXOMA Granted First European Patent Covering XOMA 052http://investors.xoma.com/releasedetail.cfm?ReleaseID=421744Wed, 04 Nov 2009 13:03:18 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421744XOMA Granted First European Patent Covering XOMA 052XOMA to Announce Third Quarter 2009 Financial Results and Host Conference Call on November 9http://investors.xoma.com/releasedetail.cfm?ReleaseID=421644Tue, 03 Nov 2009 22:23:07 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421644XOMA to Announce Third Quarter 2009 Financial Results and Host Conference Call on November 9XOMA Signs Antibody Discovery Collaboration With Kaketsukenhttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421294Tue, 03 Nov 2009 13:02:47 GMThttp://investors.xoma.com/releasedetail.cfm?ReleaseID=421294XOMA Signs Antibody Discovery Collaboration With Kaketsuken